市場調查報告書
商品編碼
370974

美國的心摶出量監測市場分析

Cardiac Output Monitoring Market Report | United States | 2019-2025 | MedCore

出版日期: | 出版商: iData Research Inc. | 英文 516 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供美國的心摶出量監測設備的市場相關分析,技術、產品概要,及整體市場規模的成果值、預測值,各監測手法及各產品詳細趨勢,主要的推動及阻礙市場要素,主要企業的市場佔有率等調查評估。

摘要整理

美國的病患監測設備、設備市場概要

競爭分析

市場趨勢

分析對象市場

市場發展

主要報告的更新情形

過去的版本

調查手法

  • 調查範圍
  • IDATA的9等級分析方法

心摶出量監測市場

  • 簡介
    • Fick原理
    • 稀釋法
    • 多普勒式超音波法
    • 脈壓法
    • 其他技術
  • 市場概要
  • 市場分析與預測
    • 肺動脈導管市場 (全體)
      • 標準型 (Bolus) 熱稀釋式肺動脈導管市場
      • 特殊肺動脈導管市場
    • 低侵入性心摶出量監測市場 (全體)
      • 低侵入性心摶出量螢幕市場
      • 低侵入性心摶出量感測器市場
    • 非侵入性心摶出量監測市場 (全體)
      • 非侵入性心摶出量螢幕市場
      • 非侵入性心摶出量感測器市場
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 各企業市場佔有率分析

簡稱一覽

目錄
Product Code: iDATA_USPME19_MC_COM

Cardiac output (CO) refers to the volume of blood being pumped by the heart. Monitoring of patient cardiac output is rapidly becoming a standard of care and a vital part of early diagnosis and treatment. It is also important in the management of heart attacks and for monitoring of sepsis patients. The inclusion of cardiac output monitoring in treatments provides valuable information on the volume tissue perfusion and oxygen delivery. Low cardiac output indicates that there is insufficient circulation and potential starvation of vital internal organs.

With ongoing improvements in reading accuracy, it is expected that the non-invasive and minimally invasive technologies will drive growth in the ICU and ER market, while cannibalizing the procedural volume of PAC treatments in the OR. Over the forecast period, the minimally and non-invasive monitoring segments will continue to grow, motivated in part by demand-driven product advancements. Modern non-invasive technologies are greatly improved and have become more widely accepted as an alternative to invasive CO monitoring in some settings.

Table of Contents

TABLE OF CONTENTS I

LIST OF FIGURES XVIII

LIST OF CHARTS XX

EXECUTIVE SUMMARY 1

U.S. PATIENT MONITORING EQUIPMENT MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 9

MARKET DEVELOPMENTS 11

MARKETS INCLUDED 14

KEY REPORT UPDATES 19

VERSION HISTORY 19

RESEARCH METHODOLOGY 20

    • Step 1: Project Initiation & Team Selection 20
    • Step 2: Prepare Data Systems and Perform Secondary Research 23
    • Step 3: Preparation for Interviews & Questionnaire Design 25
    • Step 4: Performing Primary Research 26
    • Step 5: Research Analysis: Establishing Baseline Estimates 28
    • Step 6: Market Forecast and Analysis 29
    • Step 7: Identify Strategic Opportunities 31
    • Step 8: Final Review and Market Release 32
    • Step 9: Customer Feedback and Market Monitoring 33

CARDIAC OUTPUT MONITORING MARKET 34

  • 2.1 INTRODUCTION 34
    • 2.1.1 The Fick Principle 34
    • 2.1.2 Dilution Methods 35
    • 2.1.3 Doppler Ultrasound Methods 35
    • 2.1.4 Pulse Pressure Methods 36
    • 2.1.5 Other Methods 36
  • 2.2 MARKET OVERVIEW 37
  • 2.3 MARKET ANALYSIS AND FORECAST 42
    • 2.3.1 Total Pulmonary Artery Catheter Market 42
      • 2.3.1.1 Standard (Bolus) Thermodilution Pulmonary Artery Catheter Market 47
      • 2.3.1.2 Specialty Pulmonary Artery Catheter Market 49
    • 2.3.2 Total Minimally Invasive Cardiac Output Monitoring Market 51
      • 2.3.2.1 Minimally Invasive Cardiac Output Monitor Market 56
      • 2.3.2.2 Minimally Invasive Cardiac Output Sensor Market 58
    • 2.3.3 Total Non-Invasive Cardiac Output Monitoring Market 60
      • 2.3.3.1 Non-Invasive Cardiac Output Monitor Market 65
      • 2.3.3.2 Non-Invasive Cardiac Output Sensor Market 67
  • 2.4 DRIVERS AND LIMITERS 69
    • 2.4.1 Market Drivers 69
    • 2.4.2 Market Limiters 70
  • 2.5 COMPETITIVE MARKET SHARE ANALYSIS 72

ABBREVIATIONS 78

APPENDIX: COMPANY PRESS RELEASES 81

  • 4.1 INTRODUCTION 81
  • 4.2 PRESS RELEASES 81
    • 4.2.1 Draeger Medical 82
      • 4.2.1.1 First half of 2018: Drager increases net sales 82
      • 4.2.1.2 New HealthTrust Agreement Covers Drager's Line of Anesthesia Solutions 83
      • 4.2.1.3 Drager and ICON Prepared to Support Hospitals with Ventilators During Times of Crisis 84
      • 4.2.1.4 Drager First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems 84
      • 4.2.1.5 Drager Infinity M300 Monitor Now Features FIPS Security 85
      • 4.2.1.6 Drager First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems 87
      • 4.2.1.7 Drager to Discuss Alarm Management and Strategies for Eliminating "Alarm Fatigue" at HIMSS16 88
    • 4.2.2 Edwards Lifesciences 90
      • 4.2.2.1 Edwards Lifesciences Reports Second Quarter Results 90
      • 4.2.2.2 Edwards' Acumen Hypotension Prediction Index Launches In The U.S. 92
      • 4.2.2.3 Edwards Lifesciences Reports Fourth Quarter Results 93
      • 4.2.2.4 Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 96
      • 4.2.2.5 Edwards Acquires Harpoon Medical 98
      • 4.2.2.6 Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance 98
      • 4.2.2.7 Edwards Lifesciences Reports Fourth Quarter Results 99
      • 4.2.2.8 Edwards Lifesciences Completes Acquisition Of Valtech Cardio 102
      • 4.2.2.9 Edwards Receives CE Mark For Hypotension Probability Indicator 104
      • 4.2.2.10 Edwards Lifesciences Reports Second Quarter Results 105
      • 4.2.2.11 Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors 105
      • 4.2.2.12 Edwards Lifesciences Reports First Quarter Results 106
      • 4.2.2.13 Steven Loranger Appointed To Edwards Lifesciences Board Of Directors 108
      • 4.2.2.14 Edwards Lifesciences Reports Fourth Quarter Results 109
    • 4.2.3 Fukuda Denshi 113
      • 4.2.3.1 Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S. A High Performance Color Portable Ultrasound Unit Designed for a Wide Array of Specialty Markets 113
      • 4.2.3.2 Hospitals, Healthcare Providers to Save with the Fukuda Denshi USA Inc. and Amerinet Choice License and Supply Agreement 113
    • 4.2.4 GE Healthcare 115
      • 4.2.4.1 GE Healthcare Introduces Virtual Reality Training for Healthcare Technology Management Professionals 115
      • 4.2.4.2 GE Healthcare and FitTrace announce collaboration to offer body composition analysis software for sports and fitness markets 116
      • 4.2.4.3 GE Healthcare and Preventice Solutions Collaborate to Extend the Heart Station Beyond the Hospital 117
      • 4.2.4.4 Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion 118
      • 4.2.4.5 GE Healthcare, Ferozsons L.L. and P&SHD collaborate to deliver comprehensive training program for Maternal, Newborn & Child Health (MNCH) 119
      • 4.2.4.6 Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom's healthcare sector 120
      • 4.2.4.7 GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment 122
      • 4.2.4.8 Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years 123
      • 4.2.4.9 GE Healthcare Receives Carequality Certification, Advancing Data Exchange with Cloud Technology 124
      • 4.2.4.10 Catherine Estrampes appointed President & CEO of GE Healthcare Europe 126
      • 4.2.4.11 GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes 127
      • 4.2.4.12 Emmanuel Ligner named President and CEO of GE Healthcare Life Sciences 128
      • 4.2.4.13 GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration 128
      • 4.2.4.14 Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 130
      • 4.2.4.15 Refurbished Parts for GE Diagnostic Imaging Equipment Now Available from GE Healthcare 131
      • 4.2.4.16 Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey 132
      • 4.2.4.17 GE to help transform over 200 hospitals in Egypt with 700 units of its advanced healthcare technologies 135
      • 4.2.4.18 GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare 136
      • 4.2.4.19 Boston Children's Hospital and GE Healthcare Working Together to Create Smart Imaging Technology to Better Detect Pediatric Brain Disorders 137
      • 4.2.4.20 GE Healthcare showcases industry-first technologies and digital solutions, focused on improving outcomes, at RSNA 2016 139
      • 4.2.4.21 GE Healthcare Taps Into $28 Billion Orphaned IP Market With Stake in Pilot Lite Ventures 140
      • 4.2.4.22 UC San Francisco and GE Healthcare Launch Deep Learning Partnership to Advance Care Globally 141
      • 4.2.4.23 Exploring digital solutions to combat heart disease 143
      • 4.2.4.24 The OR Goes Digital: New Apps Drive Operational and Economic Outcomes 143
      • 4.2.4.25 GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea 144
      • 4.2.4.26 See. Click. Send. New Cloud-based Ultrasound Solution Enables Instant, Enhanced Collaboration Among Clinicians 145
      • 4.2.4.27 GE to invest €150 million in biopharmaceutical manufacturing campus in Cork, Ireland, and establish advanced manufacturing training centre at NIBRT 147
      • 4.2.4.28 Boosting Compact Ultrasound IQ: GE Healthcare's New Vivid™ iq Combines Power and Portability 148
      • 4.2.4.29 GE Healthcare launches next generation Biacore molecular interaction analysis platform 149
      • 4.2.4.30 GE Healthcare and Uppsala BIO form a new partnership 150
      • 4.2.4.31 Charles Koontz Appointed President and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer 151
    • 4.2.5 Honeywell Life Sciences 152
      • 4.2.5.1 Honeywell Incorporates Integrated Video Capability Into Telehealth Platform Allowing Healthcare Professionals To Treat Patients In Their Homes 152
      • 4.2.5.2 Honeywell Unveils New Version of FDA-Cleared Telehealth Software 153
      • 4.2.5.3 Honeywell Presents Its Latest Connected Technologies That Help Reduce Clinical Errors At Saudi Health Exhibition 155
      • 4.2.5.4 Honeywell Hosts Annual Investor Conference; Reaffirms First Quarter And Full-Year 2016 Outlook; Targets 2017 Core Organic Sales Up 4-5% 156
    • 4.2.6 Masimo 157
      • 4.2.6.1 New Study Investigates Impact of General Ward Clinical Monitoring Using Masimo Root®, Radius-7®, and Patient SafetyNet™ on Clinical Workflow and Patient Care 157
      • 4.2.6.2 New Study Investigates the Utility of Masimo Pvi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery 159
      • 4.2.6.3 Masimo Announces Vital Signs Check Application for the Root® Patient Monitoring and Connectivity Platform 160
      • 4.2.6.4 New Study Investigates the Utility of Masimo Ori™ (Oxygen Reserve Index) in Providing Early Detection of Blood Oxygenation Decrease During One-Lung Ventilation 161
      • 4.2.6.5 United Arab Emirates Ministry of Health & Prevention Adopts National CCHD Newborn Screening Program Using Masimo Rad-97™ Pulse CO-Oximeters® with Eve™ 162
      • 4.2.6.6 Masimo and PositiveID Announce the U.S. Release of TIR-1™ 164
      • 4.2.6.7 New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers 165
      • 4.2.6.8 New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration 166
      • 4.2.6.9 Women's Tennis Association to Use Masimo MightySat™ Fingertip Pulse Oximeters to Advance Player Health and Performance 167
      • 4.2.6.10 New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® in Reducing Unnecessary Blood Transfusions 168
      • 4.2.6.11 Masimo SET® Pulse Oximetry Helps Form Basis of Utah Senate Resolution on Postoperative Oxygen Saturation Home Monitoring for Patients Prescribed Opioids 169
      • 4.2.6.12 Masimo Reports First Quarter 2018 Financial Results 171
      • 4.2.6.13 New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices 175
      • 4.2.6.14 Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® with Integrated NomoLine™ Capnography 176
      • 4.2.6.15 Masimo Announces UniView™ 177
      • 4.2.6.16 New Study Investigates the Performance of Masimo SpHb® During Acute Bleeding and After Fluid Resuscitation 179
      • 4.2.6.17 Masimo Announces Replica™ 180
      • 4.2.6.18 Leading Nephrology Care Center in India Adopts Masimo Technologies Across Continuum of Care 180
      • 4.2.6.19 New Study Evaluates the Performance of Masimo SpHb® in Monitoring Pediatric Trauma Patients 181
      • 4.2.6.20 New Study Evaluates the Performance of Masimo Pvi® as a Predictor of Fluid Responsiveness in Mechanically Ventilated ICU Patients 182
      • 4.2.6.21 Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter® 183
      • 4.2.6.22 Masimo Announces FDA Clearance of Next Generation SedLine® Brain Function Monitoring 184

LIST OF CHARTS

  • Chart 1 1: Patient Monitoring Equipment Market by Segment, U.S., 2015 - 2025 3
  • Chart 1 2: Patient Monitoring Equipment Market Overview, U.S., 2018 & 2025 3
  • Chart 2 1: Cardiac Output Monitoring Market by Segment, U.S., 2015 - 2025 39
  • Chart 2 2: Cardiac Output Monitoring Market Breakdown, U.S., 2018 40
  • Chart 2 3: Cardiac Output Monitoring Market Breakdown, U.S., 2025 41
  • Chart 2 4: Total Pulmonary Artery Catheter Market by Segment, U.S., 2015 - 2025 44
  • Chart 2 5: Total Pulmonary Artery Catheter Market, U.S., 2015 - 2025 46
  • Chart 2 6: Standard (Bolus) Thermodilution Pulmonary Artery Catheter Market, U.S., 2015 - 2025 48
  • Chart 2 7: Specialty Pulmonary Artery Catheter Market, U.S., 2015 - 2025 50
  • Chart 2 8: Total Minimally Invasive Cardiac Output Monitoring Market by Segment, U.S., 2015 - 2025 53
  • Chart 2 9: Total Minimally Invasive Cardiac Output Monitoring Market, U.S., 2015 - 2025 55
  • Chart 2 10: Minimally Invasive Cardiac Output Monitor Market, U.S., 2015 - 2025 57
  • Chart 2 11: Minimally Invasive Cardiac Output Sensor Market, U.S., 2015 - 2025 59
  • Chart 2 12: Total Non-Invasive Cardiac Output Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 62
  • Chart 2 13: Total Non-Invasive Cardiac Output Monitoring Market, U.S., 2015 - 2025 64
  • Chart 2 14: Non-Invasive Cardiac Output Monitor Market, U.S., 2015 - 2025 66
  • Chart 2 15: Non-Invasive Cardiac Output Sensor Market, U.S., 2015 - 2025 68
  • Chart 2 16: Leading Competitors, Cardiac Output Monitoring Market, U.S., 2018 77

LIST OF FIGURES

  • Figure 1 1: Patient Monitoring Device Market Share Ranking by Segment, U.S., 2018 (1 of 2) 4
  • Figure 1 2: Patient Monitoring Device Market Share Ranking by Segment, U.S., 2018 (2 of 2) 5
  • Figure 1 3: Companies Researched in this Report, U.S., 2018 (1 of 3) 6
  • Figure 1 4: Companies Researched in this Report, U.S., 2018 (2 of 3) 7
  • Figure 1 5: Companies Researched in this Report, U.S., 2018 (3 of 3) 8
  • Figure 1 6: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (1 of 2) 9
  • Figure 1 7: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (2 of 2) 10
  • Figure 1 8: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (1 of 3) 11
  • Figure 1 9: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (2 of 3) 12
  • Figure 1 10: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (3 of 3) 13
  • Figure 1 11: Patient Monitoring Equipment Markets Covered, U.S., 2018 (1 of 5) 14
  • Figure 1 12: Patient Monitoring Equipment Markets Covered, U.S., 2018 (2 of 5) 15
  • Figure 1 13: Patient Monitoring Equipment Markets Covered, U.S., 2018 (3 of 5) 16
  • Figure 1 14: Patient Monitoring Equipment Markets Covered, U.S., 2018 (4 of 5) 17
  • Figure 1 15: Patient Monitoring Equipment Markets Covered, U.S., 2018 (5 of 5) 18
  • Figure 1 16: Key Report Updates 19
  • Figure 1 17: Version History 19
  • Figure 2 1: Cardiac Output Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 38
  • Figure 2 2: Total Pulmonary Artery Catheter Market by Segment, U.S., 2015 - 2025 (US$M) 43
  • Figure 2 3: Total Pulmonary Artery Catheter Market, U.S., 2015 - 2025 45
  • Figure 2 4: Standard (Bolus) Thermodilution Pulmonary Artery Catheter Market, U.S., 2015 - 2025 47
  • Figure 2 5: Specialty Pulmonary Artery Catheter Market, U.S., 2015 - 2025 49
  • Figure 2 6: Total Minimally Invasive Cardiac Output Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 52
  • Figure 2 7: Total Minimally Invasive Cardiac Output Monitoring Market, U.S., 2015 - 2025 54
  • Figure 2 8: Minimally Invasive Cardiac Output Monitor Market, U.S., 2015 - 2025 56
  • Figure 2 9: Minimally Invasive Cardiac Output Sensor Market, U.S., 2015 - 2025 58
  • Figure 2 10: Total Non-Invasive Cardiac Output Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 61
  • Figure 2 11: Total Non-Invasive Cardiac Output Monitoring Market, U.S., 2015 - 2025 63
  • Figure 2 12: Non-Invasive Cardiac Output Monitor Market, U.S., 2015 - 2025 65
  • Figure 2 13: Non-Invasive Cardiac Output Sensor Market, U.S., 2015 - 2025 67
  • Figure 2 14: Drivers and Limiters, Cardiac Output Monitoring Market, U.S., 2018 71
  • Figure 2 15: Leading Competitors, Cardiac Output Monitoring Market, U.S., 2018 76
  • Figure 4 1: Press Release Summary 81